Cholangiocarcinoma in a 33-year-old male with CD40L deficiency and pre-papillary bile duct stenosis
Britta F Zecher1, Guido Schachschal2, Isabel Molwitz3
1University Medical Center Hamburg-Eppendorf, I. Department of Medicine, Germany, Hamburg.
Insights
CD40L deficiency, a cause of X-linked hyper IgM syndrome, can lead to bile duct cancer in adult males. Early screening for bile duct issues and close monitoring for malignancy are crucial for these patients.
Area of Science:
- Immunology
- Gastroenterology
- Oncology
Background:
- X-linked hyper IgM syndrome (XHIGM) results from CD40L deficiency, a rare primary immunodeficiency.
- Adult males with XHIGM frequently develop sclerosing cholangitis.
- Cholangiopathy and malignancy are known complications, necessitating vigilant monitoring.
Purpose of the Study:
- To report a unique case of distal cholangiocarcinoma in a patient with CD40L deficiency.
- To emphasize the importance of screening for cholangiopathy in individuals with CD40L deficiency.
- To highlight the need for close monitoring for malignancy in this patient population.
Main Methods:
- Case report of a 33-year-old male patient with CD40L deficiency.
- Clinical and diagnostic evaluation for hepatobiliary abnormalities.
- Review of literature concerning XHIGM and associated malignancies.
Main Results:
- The patient presented with long-standing pre-papillary bile duct stenosis, not typical sclerosing cholangitis.
- The patient subsequently developed distal cholangiocarcinoma.
- This case underscores the risk of malignancy in CD40L-deficient individuals.
Conclusions:
- Individuals with CD40L deficiency are at increased risk for developing cholangiocarcinoma.
- Screening for bile duct abnormalities and monitoring for malignancy are essential in managing CD40L deficiency.
- Early detection and management of hepatobiliary complications can improve outcomes.
Abstract:
X-linked hyper IgM-syndrome caused by CD40L deficiency is a rare primary immunodeficiency. Affected male individuals who reach adulthood often develop sclerosing cholangitis. Here, we report the case of a 33-year-old patient with long-standing solitary pre-papillary bile duct stenosis but without further signs of sclerosing cholangitis, who developed distal cholangiocarcinoma. Given the increased risk of malignancy in these patients, this case highlights, that individuals with CD40L deficiency should be screened for the presence of cholangiopathy and be closely monitored for any signs of disease progression, development of hepatobiliary dysplasia or malignancy.
